Buys
Open market- Shares
- Avg price
- Total value
Paul Andrew Moore - Chief Scientific Officer at Zymeworks Inc.
Issuer-level insider activity
- Role
- Chief Scientific Officer
- Issuer ticker
- ZYME on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Paul Andrew Moore in Zymeworks Inc.
Sells
Open market- Shares
- -29,670
- Avg price
- $24.32
- Total value
- -$721,457
Net
Past year- Shares
- -29,670
- Share %
- -100%
- Total value
- -$721,457
Reported holdings for Paul Andrew Moore in Zymeworks Inc.
Form 4 holding
Chief Scientific Officer
Zymeworks Inc.
- Security class
- Common Stock
- Shares / value
- 48,497
- Estimated value
- $1,099,596
- Report date
- 12 Jan 2026
- Price
- $22.67
- Ownership
- Direct
Form 4 holding
Chief Scientific Officer
Zymeworks Inc.
- Security class
- Restricted Stock Unit
- Shares / value
- 47,000
- Estimated value
- $790,977
- Report date
- 12 Jan 2026
- Price
- $14.92
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Scientific Officer
Zymeworks Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 70,000
- Estimated value
- Report date
- 12 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Scientific Officer
Zymeworks Inc.
- Security class
- Performance Stock Unit
- Shares / value
- 66,000
- Estimated value
- Report date
- 12 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Paul Andrew Moore in Zymeworks Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.